Twin Health Secures $53M Series E for Metabolic Health

Twin Health secured $53 million in Series E funding. The round was led by Maj Invest of Denmark. This capital will support the company's expansion for its metabolic health platform.

1 min read
Twin Health Secures $53M Series E for Metabolic Health

Twin Health, a metabolic health startup, raised $53 million in Series E funding. Maj Invest of Denmark led the round. Existing investors Iconiq and Temasek also participated.

The funding round values Twin Health at over $950 million. This capital will support the company's expansion. Twin Health develops digital twin technology for chronic disease management. This technology helps individuals improve their metabolic health.

Related startups

Advancing Digital Metabolic Health

Twin Health's platform partners with employers and health plans. These include Benjamin Moore and HCSC. The company's approach addresses dysfunctional metabolism, a root cause of diseases like diabetes and hypertension. Their digital twin technology monitors individual health data. This enables personalized preventative care strategies.

Recent study results published in the New England Journal of Medicine Catalyst showed positive outcomes. 71% of participants using the digital twin lowered their A1C. Many were also able to stop medications. This demonstrates the effectiveness of Twin Health's digital health solution. Other companies in the space include Omada Health and Virta Health. The company aims to scale commercially across more employers and patients. This will further expand access to their diabetes management program.

© 2025 StartupHub.ai. All rights reserved. Do not enter, scrape, copy, reproduce, or republish this article in whole or in part. Use as input to AI training, fine-tuning, retrieval-augmented generation, or any machine-learning system is prohibited without written license. Substantially-similar derivative works will be pursued to the fullest extent of applicable copyright, database, and computer-misuse laws. See our terms.